Use "Quotation Marks" For Exact Match

Lung Disease Forum Lung Disease News Lung Disease Articles Lung Disease Info Lung Disease Resources Site Map
  Please login Log in Join
You are at: Home » Lung Disease In HIV AIDS News
Print

Lung Diseases in HIV /AIDS News Articles

Select News Articles on Opportunistic Lung Diseases in HIV /AIDS and Immunodeficient Patients, sorted in reverse chronological order.
News Item Posted by forumadmin - Last Updated: 2005-11-09

GAMMAGARD LIQUID / Immune Globulin Intravenous (Human) IVIG Now Available in USA for the Treatment of Primary Immunodeficiencies

Baxter Healthcare Corporation has recently announced the availability of their GAMMAGARD LIQUID (IVIG) 10% Solution for the treatment of primary immunodeficiencies to patients in the United States. The company is to restrict the use of its current product GAMMAGARD S/D to only those patients that require a low Immunoglobulin A (IgA) therapy.

Read More

 
FDA Approved : Interactive Breathing Device
A Natural, Relaxing and Clinically Proven Way to Manage Blood Pressure
Helps You Breath Easy and Lowers Your Blood Pressure
RESPeRATE
Respiratory Disorders
Acute Respiratory Distress Syndrome
Acute Sinusitis
Adenocarcinoma
Allergic Bronchopulmonary Aspergillosis
ABPA
Alpha-1 Antitrypsin Deficiency
Anthrax
Asbestosis
Aspiration Pneumonia
Asthma
Atelectasis
Berylliosis
Black Lung Disease
Blastomycosis
BOOP
BPD
Bronchiectasis
Bronchiolitis Obliterans Organizing Pneumonia
Bronchogenic Carcinoma
Bronchopulmonary Dysplasia
Chlamydia Pneumonia
Chronic Bronchitis
Chronic Cough
Chronic Fibrosis
Chronic Obstructive Pulmonary Disease
Chronic Sinusitis
Coccidioidomycosis
Common Cold
COPD
Croup
Cyanosis
Cystic Fibrosis
Diaphragmatic Hernias
Emphysema
Ethmoid Sinusitis
Ethmoiditis
Farmer's Lung Disease
Flu
Frontal Sinusitis
Fungal Pneumonia
Hantavirus
HAPE
Hay Fever
Hiatus Hernias
High Altitude Pulmonary Edema
Histoplasmosis
Idiopathic Pulmonary Fibrosis
Influenza
Insomnia
Interstitial Pulmonary Fibrosis
IPF
Laryngitis
Legionellosis
Lung Cancer
Lung Disease in HIV/AIDS patients
Lymphangioleiomyomatosis -  LAM
Maxillary Sinusitis
Mesothelioma - Asbestos Cancer
Neurogenic Pulmonary Edema - NPE
Mixed Small Cell/Large Cell Lung Cancer  MSCLCLC
Non Small Cell Lung Cancer  NSCLC
Pericardial Mesothelioma
Peritoneal Mesothelioma
Pharyngitis
Pleural Mesothelioma
Pleurisy
Pneumonia
Pneumothorax
Primary Alveolar Hypoventilation Syndrome
Pulmonary Alveolar Proteinosis
Pulmonary Embolus
Pulmonary Fibrosis
Pulmonary Hypertension
Reactive Airway Disease
Respiratory Acidosis
Respiratory Alkalosis
Respiratory Distress Syndrome
Respiratory Syncytial Virus (RSV)
Restrictive Airway Disease RAD
Rhinosinusitis
Sarcoidosis
Severe Acute Respiratory Syndrome SARS
Sick Building Syndrome
Silicosis
Sinus Infections
Sinusitis
Sleep Apnea
Small Cell Lung Cancer
Solitary Pulmonary Nodules
Spontaneous Pneumothorax
Tonsillitis
Tuberculosis
Valley Fever
Wegener's Granulomatosis
Whooping Cough / Pertussis



Lung Cancer News   Member Published Pages   Lung Cancer   Mesothelioma   Asbestosis   Lung Disease   Lung Cancer Forum Home
Lung Cancer Asbestosis, Mesothelioma Resources   Lung Organizations   Lung Disease Resources   Lung Disease Forum Sitemap   FAQ   AUP
(c) 2003-2006 Mesothelioma-Asbestosis.Info. All rights reserved.
Content Published for Interactive, Personal, and Informational Use at This Site Only. Unauthorized use in any other form is strictly prohibited.

Welcome to Mesotheliom-Asbestosis Lung Cancer Resource Center. Mesothelioma Asbestosis Resource Center focuses on Lung Disease, Asbestos Lung Cancer, Asbestosis, and Mesothelioma. Offers many easy-to-use ePublishing resources to its members -for submittting lung cancer related articles, publishing news related to Lung cancer, Asbestosis, and Mesothelioma, and for participating in ongoing discussions. No programming knowhow needed. If you are reading this text, you are probably not experiencing this website to its best. Considering that we make extensive use of CSS, may we humbly suggest you revisit this site using a CSS-capable web-browser and experience this site to its fullest? We look forward to you revisting us again. Thank you.